Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer

Quinn MC, McCue K, Shi W, Johnatty SE, Beesley J, Civitarese A, O'Mara TA, Glubb DM, Tyrer JP, Armasu SM, Ong JS, Gharahkhani P, Lu Y, Gao B, Patch AM, Fasching PA, Beckmann M, Lambrechts D, Vergote I, Velez Edwards DR, Beeghly-Fadiel A, Benitez J, Garcia MJ, Goodman MT, Dörk T, Dürst M, Modugno F, Moysich K, Du Bois A, Pfisterer J, Bauman K, Karlan BY, Lester J, Cunningham JM, Larson MC, McCauley BM, Kjaer SK, Jensen A, Hogdall CK, Hogdall E, Schildkraut JM, Riggan MJ, Berchuck A, Cramer DW, Terry KL, Bjorge L, Webb PM, Friedlander M, Pejovic T, Moffitt M, Glasspool R, May T, Ene GE, Huntsman DG, Woo M, Carney ME, Hinsley S, Heitz F, Fereday S, Kennedy CJ, Edwards SL, Winham SJ, DeFazio A, Pharoah PD, Goode EL, MacGregor S, Chenevix-Trench G (2021)


Publication Type: Journal article

Publication year: 2021

Journal

Book Volume: 30

Pages Range: 1669-1680

Journal Issue: 9

DOI: 10.1158/1055-9965.EPI-20-1817

Abstract

Background: Many loci have been found to be associated with risk of epithelial ovarian cancer (EOC). However, although there is considerable variation in progression-free survival (PFS), no loci have been found to be associated with outcome at genome-wide levels of significance. Methods: We carried out a genome-wide association study (GWAS) of PFS in 2, 352 women with EOC who had undergone cytoreductive surgery and standard carboplatin/paclitaxel chemotherapy. Results: We found seven SNPs at 12q24.33 associated with PFS (P < 5 × 10-8), the top SNP being rs10794418 (HR = 1.24; 95% CI, 1.15-1.34; P = 1.47 × 10-8). High expression of a nearby gene, ULK1, is associated with shorter PFS in EOC, and with poor prognosis in other cancers. SNP rs10794418 is also associated with expression of ULK1 in ovarian tumors, with the allele associated with shorter PFS being associated with higher expression, and chromatin interactions were detected between the ULK1 promoter and associated SNPs in serous and endometrioid EOC cell lines. ULK1 knockout ovarian cancer cell lines showed significantly increased sensitivity to carboplatin in vitro. Conclusions: The locus at 12q24.33 represents one of the first genome-wide significant loci for survival for any cancer. ULK1 is a plausible candidate for the target of this association. Impact: This finding provides insight into genetic markers associated with EOC outcome and potential treatment options.

Authors with CRIS profile

Involved external institutions

QIMR Berghofer Medical Research Institute (früher: the Queensland Institute of Medical Research) AU Australia (AU) Princess Margaret Cancer Centre / Princess Margaret Hospital CA Canada (CA) University of British Columbia CA Canada (CA) BC Cancer Research Centre CA Canada (CA) University of Cambridge GB United Kingdom (GB) University of Glasgow GB United Kingdom (GB) Mayo Clinic US United States (USA) (US) Kliniken Essen-Mitte DE Germany (DE) Peter MacCallum Cancer Centre AU Australia (AU) Westmead Institute for Medical Research AU Australia (AU) Westmead Hospital AU Australia (AU) University of California Los Angeles (UCLA) US United States (USA) (US) Flanders Institute for Biotechnology / Vlaams Instituut voor Biotechnologie (VIB) BE Belgium (BE) University Hospital Leuven (UZ) / Universitaire ziekenhuizen Leuven BE Belgium (BE) Vanderbilt University US United States (USA) (US) Vanderbilt University Medical Center US United States (USA) (US) Spanish National Cancer Research Centre / Centro Nacional de Investigaciones Oncológicas (CNIO) ES Spain (ES) Cedars-Sinai Medical Center US United States (USA) (US) Medizinische Hochschule Hannover (MHH) / Hannover Medical School DE Germany (DE) Universitätsklinikum Jena DE Germany (DE) University of Pittsburgh US United States (USA) (US) Roswell Park Cancer Institute US United States (USA) (US) Philipps-Universität Marburg DE Germany (DE) University of Copenhagen DK Denmark (DK) Kræftens Bekæmpelse DK Denmark (DK) Emory University US United States (USA) (US) Duke University Medical Center US United States (USA) (US) Harvard University US United States (USA) (US) Haukeland University Hospital / Haukeland universitetssykehus NO Norway (NO) University of New South Wales (UNSW) AU Australia (AU) Oregon Health and Science University (OSHU) US United States (USA) (US) University of Hawaii (U.H.) US United States (USA) (US)

How to cite

APA:

Quinn, M.C., McCue, K., Shi, W., Johnatty, S.E., Beesley, J., Civitarese, A.,... Chenevix-Trench, G. (2021). Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer. Cancer Epidemiology Biomarkers & Prevention, 30(9), 1669-1680. https://doi.org/10.1158/1055-9965.EPI-20-1817

MLA:

Quinn, Michael C.J., et al. "Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer." Cancer Epidemiology Biomarkers & Prevention 30.9 (2021): 1669-1680.

BibTeX: Download